Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries

Počet záznamů: 1

1.

SYSNO	0544574
Název	Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation Registries
Tvůrce(i)	Rohla, M. (AT) Pecen, Ladislav (UIVT-O)_{RID, SAI, ORCID} Cemin, R. (IT) Patti, G. (IT) Siller-Matula, J. M. (AT) Schnabel, R. B. (DE) Huber, K. (AT) Kirchhof, P. (GB) De Caterina, R. (IT)
Zdroj.dok.	Circulation-Cardiovascular Quality and Outcomes. Roč. 14, č. 6 (2021)
Číslo článku	e006852
Druh dok.	Článek v odborném periodiku
Jazyk dok.	eng
Země vyd.	US
Klíč.slova	atrial fibrillation * chronic kidney disease * dabigatran * edoxaban * glomerular filtration rate
Trvalý link	http://hdl.handle.net/11104/0321419

Počet záznamů: 1